ALIQOPA
- Product NDC
- 50419-385
- 11-digit product format
- 504190385
- Labeler code
- 50419
- Product ID
- 50419-385_dbc41472-e015-4763-b728-b98908319302
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- copanlisib
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Application
- NDA209936
- Marketing category
- NDA
- Marketing start
- 2017-09-14
- Marketing end
- 0000-00-00
- Substance
- COPANLISIB
- Active strength
- 15 mg/mL
- Pharmacologic classes
- Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50419-385-01 | 50419038501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50419-385-01) > 4 mL in 1 VIAL, SINGLE-DOSE | 2017-09-14 | 0000-00-00 | No | No | Current |
| 50419-385-72 | 50419038572 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50419-385-72) > 4 mL in 1 VIAL, SINGLE-DOSE | 2018-10-30 | 0000-00-00 | Yes | No | Current |